Form D · Other

Nob Hill Therapeutics, Inc.

Albuquerque, NM · CIK 0001690041

Offering snapshot reported Aug 9, 2024 · SEC filing

Reported sold
$1.75M
Offering amount: $3.85M
Investors reported
17
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Jul 26, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 9, 2024Initial$1,750,649No comparison17SEC filing
Sep 20, 2021Amendment$150,000No comparisonNot reportedSEC filing
Jun 29, 2021Initial$100,000No comparison1SEC filing
Apr 12, 2021Initial$50,000No comparison1SEC filing
Nov 18, 2019Initial$75,000No comparison1SEC filing
Nov 15, 2018Initial$143,545No comparison1SEC filing
Apr 25, 2018Amendment$250,000$137,500vs Nov 15, 20161SEC filing
Nov 15, 2016Initial$112,500No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b, 4a5
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-521072

Source: Form D, filed Aug 9, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Atkins Director
Robert Calvin Goforth Director
R. Calvin Goforth Director
Noel Greenberger Director, Executive
Chris Japp Director
Mark Kidd Executive
Yun Li Director, Executive
Jee Shin Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
5901 Indian School Road, Suite 209
Albuquerque, NM, 87110